| SC 13G/A | 2021-02-16 | Palo Alto Investors LP | Aimmune Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2020-10-13 | Societe des Produits Nestle S.A. | Aimmune Therapeutics, Inc. | 100 | 100.0% | EDGAR |
| SC 13D/A | 2020-08-31 | Societe des Produits Nestle S.A. | Aimmune Therapeutics, Inc. | 12,813,247 | 19.6% | EDGAR |
| SC 13D/A | 2020-04-24 | Nestle Health Science US Holdings, Inc. | Aimmune Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Aimmune Therapeutics, Inc. | 5,622,538 | 8.8% | EDGAR |
| SC 13G/A | 2020-02-14 | Foresite Capital Fund II, L.P. | Aimmune Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2020-02-14 | Palo Alto Investors LP | Aimmune Therapeutics, Inc. | 3,380,441 | 5.3% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | Aimmune Therapeutics, Inc. | 4,040,835 | 6.4% | EDGAR |
| SC 13G/A | 2020-02-12 | Longitude Capital Partners II, LLC | Aimmune Therapeutics, Inc. | 6,013,134 | 9.5% | EDGAR |
| SC 13D/A | 2020-02-11 | Nestle Health Science US Holdings, Inc. | Aimmune Therapeutics, Inc. | 12,727,113 | 19.9% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | Aimmune Therapeutics, Inc. | 3,676,895 | 5.8% | EDGAR |
| SC 13G | 2019-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Aimmune Therapeutics, Inc. | 4,771,909 | 8.1% | EDGAR |
| SC 13G/A | 2019-02-13 | FMR LLC | Aimmune Therapeutics, Inc. | 2,099,221 | 3.6% | EDGAR |
| SC 13G/A | 2019-02-13 | Foresite Capital Fund II, L.P. | Aimmune Therapeutics, Inc. | 2,968,649 | 4.8% | EDGAR |
| SC 13G/A | 2019-02-12 | Longitude Capital Partners II, LLC | Aimmune Therapeutics, Inc. | 6,013,134 | 9.7% | EDGAR |
| SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | Aimmune Therapeutics, Inc. | 3,675,074 | 6.2% | EDGAR |
| SC 13G/A | 2019-02-04 | BlackRock Inc. | Aimmune Therapeutics, Inc. | 3,723,111 | 6.0% | EDGAR |
| SC 13D/A | 2018-12-03 | Nestle Health Science US Holdings, Inc. | Aimmune Therapeutics, Inc. | 11,727,113 | 18.9% | EDGAR |
| SC 13D | 2018-03-05 | Nestle Health Science US Holdings, Inc. | Aimmune Therapeutics, Inc. | 8,489,584 | 15.0% | EDGAR |
| SC 13G/A | 2018-02-13 | FMR LLC | Aimmune Therapeutics, Inc. | 2,570,039 | 5.1% | EDGAR |